Synapedia is an independent knowledge project about psychoactive substances and harm reduction. If the platform helps you learn something new, you can support its development.
Every bit helps keep the project alive.
Evidence-based risk assessment and known adverse effects
Risk Classification: High Risk
Kokain is associated with a high risk profile. Significant physical and psychological risks have been documented. Caution is warranted.
Aggregated from 2 verified experience reports. Community data reflects reported subjective experiences, not clinical outcomes.
The following substances carry an elevated risk of adverse interactions with Kokain. This list is not exhaustive.
For a full interaction overview, see the Interactions page.
Route of administration significantly influences the risk profile. Intravenous and inhalation routes carry substantially higher risks than oral administration. Commonly reported routes for Kokain:
general
Reinheitstest: Straßenkokain ist häufig mit Levamisol, Phenacetin oder anderen Streckmitteln verunreinigt. Reagenz-Kits und Drug-Checking-Services nutzen.
general
Kurzwirksamkeit bedeutet Binge-Risiko: Die kurze Wirkungsdauer (20–30 min) erzeugt starken Reiz zur Nachdosierung — Konsumgrenzen im Voraus festlegen.
general
Nasale Schäden: Septumschäden durch regelmäßigen nasalen Konsum. Nach dem Konsum Nase spülen (NaCl-Lösung). Strohhalm nicht teilen (Hepatitis-Risiko).
general
Absolute Kontraindikation: Niemals mit MAO-Hemmern kombinieren. Nie mit Alkohol UND gleichzeitigem Konsum — Kokaiethylen-Bildung erhöht Kardiotoxizität.
general
Herzprobleme: Kokain ist bei Herzerkrankungen absolut kontraindiziert.
general
Pausen zwischen Sitzungen: Mindestens mehrere Tage zwischen Konsumeinheiten — Dopamin-System braucht Regenerationszeit.
Based on 2 verified experience reports.
Disclaimer: This information is provided for educational purposes only and does not constitute medical advice. If you have concerns about substance use, please consult a qualified healthcare professional or contact a local drug support service.